merck-&-co.,-inc. - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

S&P 500 6,842 +0.87%

DJIA 48,355 +0.93%

Nasdaq 25,100 +0.83%

DAX 23,938 -0.11%

Gold $4,196 +0.16%

Oil $95.65 -1.08%

BTC $72,423 +1.48%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,220 +0.50%

merck-&-co.,-inc.

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Merck Terns Acquisition visualized with premium TERN-701 oncology drug concept

Pharma & Healthcare·Stocks·USA

Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears

By Maik Kemper • Mar 25, 2026

Can the Merck Terns Acquisition really plug the looming Keytruda revenue gap or is $6.7 billion just a high-risk oncology bet? Maik Kemper Editor in…